Neurocognitive testing in late-onset Tay-Sachs disease: A pilot study

Journal of Inherited Metabolic Disease

Volumn 31, Issue 4, 2008, Pages 518-523

  Elstein, D ^a   Doniger, G M ^b   Simon, E ^b   Korn Lubetzki, I ^a   Navon, R ^c   Zimran, A ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b NeuroTrax Corporation   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MIGLUSTAT;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EXPOSURE; FEMALE; GENOTYPE; HUMAN; MALE; NEUROLOGIC EXAMINATION; ONSET AGE; OUTCOME ASSESSMENT; PILOT STUDY; SCORING SYSTEM; TAY SACHS DISEASE; VERBAL COMMUNICATION;

ADULT; AGE OF ONSET; AGED; ALGORITHMS; COGNITION DISORDERS; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TAY-SACHS DISEASE;

EID: 50149111939     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-008-0884-z     Document Type: Article

References (14)

1. Brett EM, Ellis RB, Haas L et al (1973) Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients. Arch Dis Child 48: 775-785.
2. Cox TM, Aerts JM, Andria G et al (2003) The role of the iminosugar N -butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: A position statement. J Inherit Metab Dis 26: 513-526.
3. Dwolatzky T, Whitehead V, Doniger GM et al (2004) Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment. J Mol Neurosci 24: 33-44.
4. Elstein D, Guedalia J, Doniger GM et al (2005) Computerized cognitive testing in patients with type I Gaucher disease: Effects of enzyme replacement and substrate reduction. Genet Med 7: 124-130.
5. Elstein D, Pastores GM, Zimran A et al. (2007) Late-Onset Tay-Sachs (LOTS) Disease: Scoring Disease Severity. Washington DC: American Neurological Association.
6. Frey LC, Ringel SP, Filley CM (2005) The natural history of cognitive dysfunction in late-onset GM2 gangliosidosis. Arch Neurol 62: 989-994.
7. Harding AE, Young EP, Schon F (1987) Adult onset supranuclear ophthalmoplegia, cerebellar ataxia, and neurogenic proximal muscle weakness in a brother and sister: Another hexosaminidase A deficiency syndrome. J Neurol Neurosurg Psychiatry 50: 687-690.
8. Hobart JC, Cano SJ, Zajicek JP, Thompson AJ (2007) Rating scales as outcome measures for clinical trials in neurology: Problems, solutions, and recommendations. Lancet Neurol 6: 1094-1105.
9. Hund E, Grau A, Fogel W et al (1997) Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings. J Neurol Sci 145: 25-31.
10. Neudorfer O, Pastores GM, Zeng BJ et al (2005) Late-onset Tay-Sachs disease: Phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med 7: 119-123.
11. Percy AK, Shapiro LJ, Kaback MM (1979) Inherited lipid storage diseases of the central nervous system. Curr Probl Pediatr 9: 1-51.
12. Platt FM, Neises GR, Reinkensmeier G et al (1997) Prevention of lysosomal storage in Tay-Sachs mice treated with N -butyldeoxynojirimycin. Science 276: 428-431.
13. Schweiger A, Doniger GM, Dwolatzky T et al (2003) Reliability of a novel computerized neuropsychological battery for mild cognitive impairment. Acta Neuropsychologica 1: 407-413.
14. Zaroff CM, Neudorfer O, Morrison C et al (2004) Neuropsychological assessment of patients with late onset GM2 gangliosidosis. Neurology 62: 2283-2286.